GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (LSE:AGY) » Definitions » Ending Cash Position

Allergy Therapeutics (LSE:AGY) Ending Cash Position : £13.52 Mil (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Allergy Therapeutics Ending Cash Position?

Allergy Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 was £13.52 Mil.

Allergy Therapeutics's quarterly Ending Cash Position declined from Dec. 2022 (£15.20 Mil) to Jun. 2023 (£14.85 Mil) and declined from Jun. 2023 (£14.85 Mil) to Dec. 2023 (£13.52 Mil).

Allergy Therapeutics's annual Ending Cash Position declined from Jun. 2021 (£40.27 Mil) to Jun. 2022 (£20.52 Mil) and declined from Jun. 2022 (£20.52 Mil) to Jun. 2023 (£14.85 Mil).

Allergy Therapeutics Ending Cash Position Historical Data

The historical data trend for Allergy Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Ending Cash Position Chart

Allergy Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.44 36.96 40.27 20.52 14.85

Allergy Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.39 20.52 15.20 14.85 13.52

Allergy Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Allergy Therapeutics's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=20.515+-5.67
=14.85

Allergy Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=14.845+-1.323
=13.52

Allergy Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Allergy Therapeutics (LSE:AGY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (LSE:AGY) » Definitions » Ending Cash Position
Comparable Companies
LSE:ANCR LSE:APH LSE:EAH LSE:CEL LSE:VLG LSE:PXS LSE:STX LSE:CHLL AQSE:ANA LSE:HELD ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
HHU:Germany
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Website
https://www.allergytherapeutics.com
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics (LSE:AGY) Headlines

No Headlines